The Development Center for Biotechnology (DCB) of Taiwan is a non-profit organization supported by the Department of Industrial Technology, Ministry of Economic Affairs. DCB’s objective is to advance Taiwan's biotech-pharma industry by building infrastructure, developing key technologies, and train talented workforces in coordination with government, industry, and academic institutions. In line with Taiwan's current biotech-pharma development policy, which emphasizes value-addition and knowledge-basis, DCB positions itself as a "Preclinical Value-Adding R&D Center for Biopharmaceuticals". This role is to be fulfilled by devoting concerted R&D efforts on protein, small molecule and botanical drug leads in the preclinical stage of development and setting top priorities for attaining Investigational New Drug approvals by domestic and foreign regulatory agencies. The division of Industrial Promotion provides industrial information, services, facilitates technology transfer, and overall foster international partnerships for commercialization. Many of these functions are performed in conjunction with outpost team members managing other government-sponsored programs, such as the Biotechnology and Pharmaceutical Industries Program Office (BPIPO; commissioned by the Industrial Development Bureau, MOEA), and the Nankang Biotech Incubation Center (NBIC; commissioned by the Small and Medium Enterprise Administration, MOEA). DCB is dedicated to R&D in botanic drug products, pharmaceuticals, biologics, animal pharmacology, and innovative and explorative research. DCB also establishes itself as a licensing technology platform. At present, the therapeutic areas for drug development include cancer, diabetes, as well as infectious, inflammatory and cardiovascular diseases.
View Top Employees from Development Center for BiotechnologyWebsite | http://www.dcb.org.tw |
Revenue | $29.2 million |
Employees | 234 (124 on RocketReach) |
Founded | 1984 |
Address | 3 Yuanqu St, Taipei, Taipei, TW |
Phone | +886 2 2695 6933 |
Industry | Biotechnology, Business Services General, Business Services |
Web Rank | 4 Million |
Keywords | Drug Development And Manufacturing, Biologics, Pharmaceutical Research, Innovative Research, Biopharmaceuticals |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541713 Companies |
Looking for a particular Development Center for Biotechnology employee's phone or email?
The Development Center for Biotechnology annual revenue was $29.2 million in 2024.
Chaio-Wen Chen is the Executive Director, Institute for Drug Evaluation Platform of Development Center for Biotechnology.
124 people are employed at Development Center for Biotechnology.
Development Center for Biotechnology is based in Taipei, Taipei.
The NAICS codes for Development Center for Biotechnology are [54, 541, 54171, 5417, 541713].
The SIC codes for Development Center for Biotechnology are [87, 873].